ResearcherChiba UniversityActive in the last 2 years
Motoyasu Kan
Matched on ORCID iD 0000-0001-8481-4551; OpenAlex author ID A5112437003. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Re… First author DOI 10.3390/cancers18020194↗
- Anamorelin as a Therapeutic Option for Cancer Cachexia in Advanced Pancreatic Cancer: A Case Report Demonstrating Significant Weight Gain and Quality of Life I… Co-author DOI 10.2169/internalmedicine.4708-24↗
- Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2021.04.001↗
- Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort… Co-author DOI 10.1007/s00280-020-04110-3↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiroshi Ohyama · 3 shared papers, 2021–2026 · strength 0.54
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194↗
- Paper Anamorelin as a Therapeutic Option for Cancer Cachexia in Advanced Pancreatic Cancer: A Case Report Demonstrating Signi… DOI 10.2169/internalmedicine.4708-24↗
- Paper Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal ad… DOI 10.1016/j.pan.2021.04.001↗
- Kazuki Watabe · 2 shared papers, 2025–2026 · strength 0.44
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194↗
- Paper Anamorelin as a Therapeutic Option for Cancer Cachexia in Advanced Pancreatic Cancer: A Case Report Demonstrating Signi… DOI 10.2169/internalmedicine.4708-24↗
- Jun Kato · 2 shared papers, 2021–2026 · strength 0.33
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194↗
- Paper Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal ad… DOI 10.1016/j.pan.2021.04.001↗
- Shigetsugu Takano · 2 shared papers, 2021–2026 · strength 0.33
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194↗
- Paper Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal ad… DOI 10.1016/j.pan.2021.04.001↗
- Masayuki Ohtsuka · 2 shared papers, 2021–2026 · strength 0.33
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194↗
- Paper Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal ad… DOI 10.1016/j.pan.2021.04.001↗
- Naoya Kato · 2 shared papers, 2021–2025 · strength 0.31
- Paper Anamorelin as a Therapeutic Option for Cancer Cachexia in Advanced Pancreatic Cancer: A Case Report Demonstrating Signi… DOI 10.2169/internalmedicine.4708-24↗
- Paper Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal ad… DOI 10.1016/j.pan.2021.04.001↗
- Akinori Abe · 1 shared paper, 2026 · strength 0.23
- Rintaro Mikata · 1 shared paper, 2021 · strength 0.10
- Kosho Asano · 1 shared paper, 2021 · strength 0.10
- Toru Otsuru · 1 shared paper, 2020 · strength 0.09
- Kumiko Umemoto · 1 shared paper, 2020 · strength 0.09
- Shuichi Mitsunaga · 1 shared paper, 2020 · strength 0.09
- Mitsuhito Sasaki · 1 shared paper, 2020 · strength 0.09
- Masafumi Ikeda · 1 shared paper, 2020 · strength 0.09
- Hiroshi Imaoka · 1 shared paper, 2020 · strength 0.09
- Gen Kimura · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.